Patent · US Active

Ready to use liquid formulation

US10952962B1 · kind B1 · utility

2Cited by

2References

16Claims

0Family size

Assignee

QuVa Pharma Inc. · US

Inventors

Travis A. Leeah · Sugar Land, US
Jianping Chen · Shanghai, CN

Key dates

Filing date	Apr 11, 2019
Grant date	Mar 23, 2021
Priority date	—
Expiry date	Jun 16, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P23/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein is a ready-to-use liquid formulation comprising lidocaine hydrochloride and epinephrine hydrochloride. Also disclosed herein is a process for preparing a ready-to-use liquid formulation comprising lidocaine hydrochloride and epinephrine hydrochloride, as well as methods for using the ready-to-use liquid formulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.